{
    "Trade/Device Name(s)": [
        "Kenota 1 Total IgE",
        "Kenota 1 instrument"
    ],
    "Submitter Information": "Kenota Inc.",
    "510(k) Number": "K231151",
    "Predicate Device Reference 510(k) Number(s)": [
        "K161899"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DGC"
    ],
    "Summary Letter Date": "May 31, 2024",
    "Summary Letter Received Date": "April 24, 2023",
    "Submission Date": "April 21, 2023",
    "Regulation Number(s)": [
        "21 CFR 866.5510"
    ],
    "Regulation Name(s)": [
        "Immunoglobulins A, G, M, D, and E immunological test system"
    ],
    "Analyte Class(es)": [
        "allergy",
        "immunology",
        "POCT"
    ],
    "Analyte(s)": [
        "Total immunoglobulin E (IgE)"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood",
        "Fingerstick whole blood"
    ],
    "Specimen Container(s)": [
        "Minivette POCT lithium-heparin tube (Sarstedt)"
    ],
    "Instrument(s)/Platform(s)": [
        "Kenota 1 instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Lateral flow immunoassay",
        "Direct fluorescence"
    ],
    "Methodologies": [
        "Solid phase immunofluorescence assay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Instrument",
        "Cartridge",
        "External Control",
        "Sample collection kit",
        "Developing solution"
    ],
    "Document Summary": "FDA 510(k) summary for Kenota 1 Total IgE lateral flow immunoassay for semi-quantitative measurement of total IgE in capillary whole blood using the Kenota 1 instrument",
    "Indications for Use Summary": "Semi-quantitative measurement of total IgE in human capillary whole blood as an aid in the clinical diagnosis of IgE-mediated allergic disorders, for use in allergist/immunologist offices with CLIA Certificate of Waiver",
    "fda_folder": "Immunology"
}